Search research articles
Contact Us
Filters
Showing results (41-50 of 141) with videos related to
Page
of 15
Sort By:
Cardiology
|
May 5, 2012
Characteristics and Outcome in Acute Coronary Syndrome Patients with and without Established Modifiable Cardiovascular Risk Factors: Insights from the Nationwide AMIS Plus Registry 1997-2010
Paul Erne, Felix Gutzwiller, Philip Urban, et al.
Mediators of Inflammation
|
June 2, 2018
Response to: Comment on "Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema"
Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, et al.
Swiss Medical Weekly
|
February 24, 2009
Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure
Alain Rudiger, Franziska Businger, Michael Streit, et al.
Journal of Intensive Care
|
August 1, 2018
Preserving fertility in an unconscious patient with Goodpasture syndrome-medicolegal and ethical aspects
Doreen Stark, Ruth Stiller, Min Xie, et al.
Mediators of Inflammation
|
July 6, 2016
Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema
Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, et al.
High Altitude Medicine & Biology
|
July 2, 2011
Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m
Christoph Siebenmann, Konrad E Bloch, Carsten Lundby, et al.
Sleep
|
October 2, 2012
Sleep and breathing in high altitude pulmonary edema susceptible subjects at 4,559 meters
Yvonne Nussbaumer-Ochsner, Nicole Schuepfer, Justyna Ursprung, et al.
Stroke
|
February 5, 2005
Effects of high altitude exposure on cerebral hemodynamics in normal subjects
Aurélie Van Osta, Jean-Jacques Moraine, Christian Mélot, et al.
Intensive Care Medicine
|
February 21, 2003
Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans
Esther B Bachli, Stephan R Vavricka, Roland B Walter, et al.
High Altitude Medicine & Biology
|
August 3, 2005
Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m)
Carlos Pesce, Conxita Leal, Hernán Pinto, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 141) with videos related to
Sort By:
Page
of 15
Cardiology
|
May 5, 2012
Characteristics and Outcome in Acute Coronary Syndrome Patients with and without Established Modifiable Cardiovascular Risk Factors: Insights from the Nationwide AMIS Plus Registry 1997-2010
Paul Erne, Felix Gutzwiller, Philip Urban, et al.
Mediators of Inflammation
|
June 2, 2018
Response to: Comment on "Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema"
Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, et al.
Swiss Medical Weekly
|
February 24, 2009
Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure
Alain Rudiger, Franziska Businger, Michael Streit, et al.
Journal of Intensive Care
|
August 1, 2018
Preserving fertility in an unconscious patient with Goodpasture syndrome-medicolegal and ethical aspects
Doreen Stark, Ruth Stiller, Min Xie, et al.
Mediators of Inflammation
|
July 6, 2016
Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema
Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, et al.
High Altitude Medicine & Biology
|
July 2, 2011
Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m
Christoph Siebenmann, Konrad E Bloch, Carsten Lundby, et al.
Sleep
|
October 2, 2012
Sleep and breathing in high altitude pulmonary edema susceptible subjects at 4,559 meters
Yvonne Nussbaumer-Ochsner, Nicole Schuepfer, Justyna Ursprung, et al.
Stroke
|
February 5, 2005
Effects of high altitude exposure on cerebral hemodynamics in normal subjects
Aurélie Van Osta, Jean-Jacques Moraine, Christian Mélot, et al.
Intensive Care Medicine
|
February 21, 2003
Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans
Esther B Bachli, Stephan R Vavricka, Roland B Walter, et al.
High Altitude Medicine & Biology
|
August 3, 2005
Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m)
Carlos Pesce, Conxita Leal, Hernán Pinto, et al.
Page
of 15